"We plan to dose our first subjects in the next weeks,40 healthy subjects and expect to report phase I interim results later this year," 2 weeks not 2 years..
Sentiment: Strong Buy
June 20 (Reuters) - Drug developer Inovio Pharmaceuticals Inc and its partner GeneOne Life Sciences Inc said they had received approval to start an early stage human trial testing their Zika vaccine.
The early-stage study will enroll 40 healthy subjects and evaluate safety, tolerability and immune response generated by the vaccine GLS-5700.
"We plan to dose our first subjects in the next weeks and expect to report phase I interim results later this year," Inovio CEO J Joseph Kim said.
(Reporting by Amrutha Penumudi in Bengaluru; Editing by Shounak Dasgupta)
I call it criminal and a breach of obligation.Showing more of how the whole thing is loosing what we once called integrity..Shame.
Its a lock..
Ya ..me too ..this is what we get from them..maybe if their paychecks whet down percentage wise they would wake up!
This is the biggest attack on this stock by far! where are these guys..If no PR now or defence..what? when ?? Get this guy/co. off their azzes AND DO SOMETHING say something to counter act this .Im only asking to tell some truths in defence..Did anyone call besides me??
Call this guy and tell him how unhappy you are,if you are, about his lack of being a "public Relations man.Whats he thinking..I did.